Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk
03/12/2025 15:50
Dec 3 (Reuters) - Akero Therapeutics Inc AKRO.O: AKERO THERAPEUTICS INC - STOCKHOLDERS APPROVE ACQUISITION BY NOVO NORDISK - SEC FILING Source text: [ID:n0001140361-25-044131] Further company coverage: AKRO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk